Aplisol (Par Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Aplisol drug offered from Par Pharmaceutical, Inc.. This Skin Test Antigen [EPC],Tuberculosis Skin Test [EPC],Cell-mediated Immunity [PE],Antigens, Bacterial [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Par Pharmaceutical, Inc. |
| NON-PROPRIETARY NAME: | Tuberculin Purified Protein Derivative |
| SUBSTANCE NAME: | TUBERCULIN PURIFIED PROTEIN DERIVATIVE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Skin Test Antigen [EPC],Tuberculosis Skin Test [EPC],Cell-mediated Immunity [PE],Antigens, Bacterial [Chemical/Ingredient] |
| ROUTE: | INTRADERMAL |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2014-04-25 |
| END MARKETING DATE: | 0000-00-00 |
Aplisol HUMAN PRESCRIPTION DRUG Details:
| Item Description | Aplisol from Par Pharmaceutical, Inc. |
| LABELER NAME: | Par Pharmaceutical, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5([iU]/.1mL) |
| START MARKETING DATE: | 2014-04-25 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 42023-104_8eb1d549-b0b1-409d-96f6-f29a807571b8 |
| PRODUCT NDC: | 42023-104 |
| APPLICATION NUMBER: | BLA103782 |
Other TUBERCULIN PURIFIED PROTEIN DERIVATIVE Pharmaceutical Manufacturers / Labelers:
